Newstral
Illumina Inc.
- Federal Antitrust Enforcers Publish 2023 Final Merger Guidelines: A Reflection of Heightened Enforcementjdsupra.com
- MIllumina to sell cancer-test maker Grail after latest antitrust ruling1 min readmarketwatch.com
- The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - November 2023jdsupra.com
- Hologic, Doximity rise; Trade Desk, Plug Power fall, Friday, 11/10/2023Seattle Times
- Will the FTC Evade a String of Constitutional Attacks?jdsupra.com
- MFTC orders Illumina to divest Grail acquisitionmvtelegraph.com
- Nashville Biosciences and Illumina Announce Sequencing Agreement With Amgen tntribune.com
- Illumina, ResMed fall; Broadridge, Humana riseSeattle Times
- MIllumina stock tanks as gene-sequencing company misses expectations and issues bleak outlook1 min readmarketwatch.com
- Clarification or Raising the Bar? PTO Director Issues New Guidance for Discretionary PTAB Denialsjdsupra.com
- New Rady program will screen infants for genetic threatssandiegouniontribune.com
- Delaware Jury Awards US$334 Million in DNA Sequencing Patent Trialjdsupra.com
- Illumina: Q1 Earnings SnapshotThe Fresno Bee
- Street Earnings Overstated For Most S&P 500 Companies In 2021Forbes
- LComprehensive Report on MiRNA Sequencing and Assay Market 2021 | Illumina Inc.,Thermo Fisher Scientific Inc.,Qiagen,Perkin Elmer Incliverpoolstudentmedia.com
- Illumina: Q4 Earnings SnapshotMerced Sun-Star
- LNorth America Metagenomics Market to Progress For Unexpected Growth Worldwide, By Packaging, By End User, By Distribution Channelliverpoolstudentmedia.com
- Big Lots, Aptiv fall; Illumina, Shake Shack riseSeattle Times
- GNon-invasive Prenatal Testing (NIPT) Market– Functional Survey 2028galleonnews.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.